Fong‐Chi Cheng

503 total citations
19 papers, 414 citations indexed

About

Fong‐Chi Cheng is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Fong‐Chi Cheng has authored 19 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Organic Chemistry and 3 papers in Oncology. Recurrent topics in Fong‐Chi Cheng's work include Chemical Synthesis and Analysis (4 papers), Receptor Mechanisms and Signaling (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Fong‐Chi Cheng is often cited by papers focused on Chemical Synthesis and Analysis (4 papers), Receptor Mechanisms and Signaling (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Fong‐Chi Cheng collaborates with scholars based in Taiwan, United States and Japan. Fong‐Chi Cheng's co-authors include Tsang‐Miao Huang, Che‐Ming Teng, Chin‐Chung Wu, Peter Chiu, Richard N. Mitchell, Fang‐Yu Lee, Jin‐Cherng Lien, William Crumb, Sheng‐Chu Kuo and Li‐Jiau Huang and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Fong‐Chi Cheng

18 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fong‐Chi Cheng Taiwan 11 231 110 82 38 37 19 414
Névéna Mollova United States 14 272 1.2× 78 0.7× 82 1.0× 29 0.8× 28 0.8× 39 478
Bryan K. Sorensen United States 13 192 0.8× 150 1.4× 70 0.9× 34 0.9× 39 1.1× 24 512
Sumaira Umbreen Germany 10 191 0.8× 126 1.1× 76 0.9× 62 1.6× 49 1.3× 14 423
Guiqing Liang United States 11 171 0.7× 104 0.9× 29 0.4× 55 1.4× 29 0.8× 21 484
Denise Blum‐Kaelin Switzerland 9 173 0.7× 65 0.6× 50 0.6× 61 1.6× 29 0.8× 11 445
Johan Malm United States 16 313 1.4× 129 1.2× 32 0.4× 48 1.3× 41 1.1× 25 995
Steven A. Boyd United States 18 322 1.4× 320 2.9× 71 0.9× 45 1.2× 63 1.7× 34 739
Gopalakrishnan Venkatesan Singapore 13 216 0.9× 80 0.7× 43 0.5× 27 0.7× 17 0.5× 29 501
Roberta Tesch Germany 14 263 1.1× 217 2.0× 37 0.5× 76 2.0× 32 0.9× 20 520
Ligaya M. Simpkins United States 13 324 1.4× 229 2.1× 25 0.3× 75 2.0× 57 1.5× 16 545

Countries citing papers authored by Fong‐Chi Cheng

Since Specialization
Citations

This map shows the geographic impact of Fong‐Chi Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fong‐Chi Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fong‐Chi Cheng more than expected).

Fields of papers citing papers by Fong‐Chi Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fong‐Chi Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fong‐Chi Cheng. The network helps show where Fong‐Chi Cheng may publish in the future.

Co-authorship network of co-authors of Fong‐Chi Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Fong‐Chi Cheng. A scholar is included among the top collaborators of Fong‐Chi Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fong‐Chi Cheng. Fong‐Chi Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Chen, Yun‐Ju, et al.. (2014). Chemical Proteomics Identifies Heterogeneous Nuclear Ribonucleoprotein (hnRNP) A1 as the Molecular Target of Quercetin in Its Anti-cancer Effects in PC-3 Cells. Journal of Biological Chemistry. 289(32). 22078–22089. 47 indexed citations
2.
Cheng, Fong‐Chi, et al.. (2009). Discovery and characterization of [3H]8-OH-DPAT binding to HeLaS3 cells. Archives of Biochemistry and Biophysics. 495(1). 14–20.
4.
Chen, Chien‐Shu, Chiung-Hua Huang, Ling‐Chu Chang, et al.. (2009). Discovery of 3-(4-bromophenyl)-6-nitrobenzo[1.3.2]dithiazolium ylide 1,1-dioxide as a novel dual cyclooxygenase/5-lipoxygenase inhibitor that also inhibits tumor necrosis factor-α production. Bioorganic & Medicinal Chemistry. 18(2). 597–604. 13 indexed citations
5.
6.
Kobayashi, Hidetaka, Sayaka Yamamoto, Hitoshi Sato, et al.. (2007). Cell cycle phenotype-based optimization of G2-abrogating peptides yields CBP501 with a unique mechanism of action at the G2 checkpoint. Molecular Cancer Therapeutics. 6(1). 147–153. 40 indexed citations
7.
Liu, Yu‐Chih, et al.. (2006). Identification of a novel competitive inhibitor of p38α MAPK by a human PBMC screen. Biochemical and Biophysical Research Communications. 352(3). 656–661. 1 indexed citations
8.
Kennedy, Deborah, et al.. (2006). An in vivo analysis of the herbal compound essiac.. PubMed. 26(4B). 3057–63. 3 indexed citations
9.
Foister, Shane, et al.. (2006). Design and Synthesis of Potent Cystine-Free Cyclic Hexapeptide Agonists at the Human Urotensin Receptor. Organic Letters. 8(9). 1799–1802. 11 indexed citations
10.
Mowery, Brendan P., et al.. (2006). Catechol:  A Minimal Scaffold for Non-Peptide Peptidomimetics of thei+ 1 andi+ 2 Positions of the β-Turn of Somatostatin. Organic Letters. 8(20). 4397–4400. 13 indexed citations
11.
Smith, Amos B., Adam K. Charnley, Eugen F. Mesaros, et al.. (2005). Design, Synthesis, and Binding Affinities of Pyrrolinone-Based Somatostatin Mimetics. Organic Letters. 7(3). 399–402. 13 indexed citations
12.
Neelamkavil, Santhosh, Byron H. Arison, Elizabeth T. Birzin, et al.. (2005). Replacement of Phe6, Phe7, and Phe11ofd-Trp8-Somatostatin-14 withl-Pyrazinylalanine. Predicted and Observed Effects on Binding Affinities at hSST2 and hSST4. An Unexpected Effect of the Chirality of Trp8on NMR Spectra in Methanol. Journal of Medicinal Chemistry. 48(12). 4025–4030. 15 indexed citations
13.
Cheng, Fong‐Chi, et al.. (2005). The Neuroprotective Effects of BNG-1: A New Formulation of Traditional Chinese Medicines for Stroke. The American Journal of Chinese Medicine. 33(1). 61–71. 10 indexed citations
15.
Chiu, Peter, et al.. (2004). Validation of a [3H]Astemizole Binding Assay in HEK293 Cells Expressing HERG K+ Channels. Journal of Pharmacological Sciences. 95(3). 311–319. 104 indexed citations
16.
Wei, Jiann-Wu, et al.. (2003). General Pharmacological Properties of Shakuyaku-kanzo-to. 64(1). 23–31. 5 indexed citations
17.
Lee, Fang‐Yu, Jin‐Cherng Lien, Li‐Jiau Huang, et al.. (2002). ChemInform Abstract: Synthesis of 1‐Benzyl‐3‐(5′‐hydroxymethyl‐2′‐furyl)indazole Analogues as Novel Antiplatelet Agents.. ChemInform. 33(10). 2 indexed citations
18.
Lee, Fang‐Yu, Jin‐Cherng Lien, Li‐Jiau Huang, et al.. (2001). Synthesis of 1-Benzyl-3-(5‘-hydroxymethyl-2‘-furyl)indazole Analogues as Novel Antiplatelet Agents. Journal of Medicinal Chemistry. 44(22). 3746–3749. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026